FDA Approved: ETODOLAC — Supplemental Application (Amneal Pharmaceuticals NY LLC)

View source ↗

Summary

FDA approved a supplemental application for etodolac from Amneal Pharmaceuticals NY LLC under ANDA 208834.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Osteoarthritis
• Rheumatoid Arthritis

Drugs mentioned

• Etodolac (Etodolac)

Snippet

SUPPL AP for ETODOLAC (ETODOLAC)